A case of systemic lupus erythematosus that manifested in the course of schizophrenia

Scandinavian Journal of Rheumatology

Volumn 31, Issue 6, 2002, Pages 374-376

  Funauchi, Masanori ^a   Yamagata, Toshiaki ^a   Nozaki, Yuji ^a   Sugiyama, Masafumi ^a   Ikoma, Shin Ya ^a   Kinoshita, Koji ^a   Kanamaru, Akihisa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti DNA antibodies; Drug induced lupus; Schizophrenia; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DNA HISTONE INTERACTION; FEMALE; GENE SWITCHING; HUMAN; IMMUNOPATHOLOGY; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SCHIZOPHRENIA;

EID: 0036440638     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097402320817121     Document Type: Article

References (16)

1. Ganguli R. Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS. Autoimmunity in schizophrenia: A review of recent findings. Ann Med 1993;25:489-96.
2. Teplizki HA, Sela B, Shoenfeld Y. Autoantibodies to brain and polynucleotides in patients with schizophrenia: A puzzle. Immunol Res 1992;11:66-73.
3. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
4. Hieronymus T, Grotsch P, Blank N, Caprau D, Winkler S, Kalden JR, et al. Chlorpromazine induces apoptosis in activated human lymphoblasts: A mechanism supporting the induction of drug-induced lupus erythematosus? Arthritis Rheum 2000;43:1994-2004.
5. LE Goff P, Saraux A. Drug-induced lupus. Rev Rheum 1999;66:40-5.
6. Shen GQ, Shoenfeld Y, Peter JB. Anti-DNA, antibodies in systemic lupus erythematosus and drug-induced lupus. Clin Rev Aller Immunol 1998;16:321-33.
7. Pramatarov KD. Drug-induced lupus erythenlatosus. Clin Dermatol 1998;16:367-77.
8. Burlingame RW. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatinin systemic lupus erythematosus and drug-induced lupus. Clin Lab Med 1997;17:367-78.
9. Vargas-Alarbon G, Yamamoto-Furusho JK, Zuniga J, Canoso R. Granados J. HLA-DR7 in association with chlorpromazine-induced lupus anticoagulant (LA). J Autoimmun 1997;10:579-83.
10. Matsukawa Y, Satoh M, Itoh T, Nishinarita S, Horie T, Abe K, et al. Plasmapheresis for a schizophrenic patient with drug-induced lupus anti-coagulant. J Int Med Res 1996;24:147-50.
11. Watanabe T, Sato T, Uchimi T, Arakawa M. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody. Lupus 1996;5:178-83.
12. Omdal R. Some controversies of neruopsychiatric systemic lupus erythematosus. Scand J Rheumatol 2002;31:192-7.
13. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1998;41:1819-27.
14. Waterloo K, Omdal R, Husby G, Mellgren SI. Emotional status in systemic lupus erythematosus. Scand J Rheumatol 1998;27:410-4.
15. Sirota P, Firer MA, Schild K, Tanay A, Elizur A, Meytes D, et al. Autoantibodies to DNA in multicase families with schizophrenia. Biol Psychiatry 1993;33:450-5.
16. Rudin DO. The choroids plexus and system disease in mental illness. Systemic lupus erythematosus: A combined transport dysfunction model for schizophrenia. Biol Psychiatry 1981;16:373-97.